3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
4
Lymphoma, T-Cell, Peripheral
3
Lymphoma, Large-Cell, Anaplastic
2
Immunoblastic Lymphadenopathy
2
Subcutaneous panniculitis-like T-cell lymphoma
1
Mycosis Fungoides
1
Lymphoma, Follicular
1
Hematologic Neoplasms
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
Cyclophosphamide
8
Rituximab
5
fludarabine
4
Vincristine
4
Prednisone
4
Doxorubicin
4
fludarabine phosphate
3
Tacrolimus
3
Mycophenolic Acid
3
Etoposide
3
Busulfan
3
venetoclax
2
entrectinib
2
atezolizumab
2
alectinib
2
acalabrutinib
2
Whole-Body Irradiation
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mesna
2
Melphalan
2
Bortezomib
2
trametinib
1
pertuzumab
1
pembrolizumab
1
obinutuzumab
1
liposomal doxorubicin
1
isatuximab
1
ibrutinib
1
etoposide phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoproliferative Disorders
×
10-propargyl-10-deazaaminopterin
×
1 year
×
Clear all
No trials found.